cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Rating)'s stock price rose 15.1% during mid-day trading on Thursday . The stock traded as high as $0.29 and last traded at $0.29. Approximately 547,954 shares were traded during mid-day trading, an increase of 175% from the average daily volume of 199,214 shares. The stock had previously closed at $0.25.
cbdMD Trading Up 17.8 %
Institutional Trading of cbdMD
Institutional investors have recently bought and sold shares of the business. Prudential Financial Inc. acquired a new stake in shares of cbdMD in the second quarter worth approximately $32,000. ExodusPoint Capital Management LP acquired a new position in cbdMD during the third quarter worth $32,000. Cambria Investment Management L.P. boosted its stake in cbdMD by 23.4% during the third quarter. Cambria Investment Management L.P. now owns 286,254 shares of the company's stock worth $64,000 after buying an additional 54,214 shares during the last quarter. Renaissance Technologies LLC boosted its stake in cbdMD by 82.6% during the second quarter. Renaissance Technologies LLC now owns 170,875 shares of the company's stock worth $75,000 after buying an additional 77,275 shares during the last quarter. Finally, Vident Investment Advisory LLC boosted its stake in cbdMD by 68.4% during the first quarter. Vident Investment Advisory LLC now owns 119,283 shares of the company's stock worth $124,000 after buying an additional 48,470 shares during the last quarter. 41.08% of the stock is owned by institutional investors and hedge funds.
cbdMD Company Profile
(Get Rating)
cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name.
Recommended Stories
- Get a free copy of the StockNews.com research report on cbdMD (YCBD)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here's Why
- Carvana Stock Rally, Here's What You Need to Know
Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.